Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities

Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities

Abstract Background In recent years a growing number of manufacturers and medical abortion products have entered country markets and health systems, with varying degrees of quality and accessibility. An interplay of factors including pharmaceutical regulations, abortion laws, government policies and...

Full description

Bibliographic Details
Main Authors: Amy Grossman, Ndola Prata, Natalie Williams, Bela Ganatra, Antonella Lavelanet, Laurence Läser, Chilanga Asmani, Hayfa Elamin, Leopold Ouedraogo, Md. Mahmudur Rahman, Musu Julie Conneh-Duworko, Bentoe Zoogley Tehoungue, Harriet Chanza, Henry Phiri, Bharat Bhattarai, Narayan Prasad Dhakal, Olumuyiwa Adesanya Ojo, Kayode Afolabi, Theopista John Kabuteni, Binyam Getachew Hailu, Francis Moses, Sithembile Dlamini-Nqeketo, Thembi Zulu, Ulrika Rehnström Loi
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Reproductive Health
Subjects:
Medical abortion
Mifepristone
Misoprostol
Combi-pack
Abortion
Online Access:https://doi.org/10.1186/s12978-023-01574-3

Internet

https://doi.org/10.1186/s12978-023-01574-3

Similar Items